Interferon Regulatory Factor 4: An Alternative Marker for Plasma Cells in Daratumumab-Treated Patients With Multiple Myeloma., PMID:39267340
SLAMF3 promotes Th17 differentiation and is reversed by iguratimod through JAK1/STAT3 pathway in primary Sjögren's syndrome., PMID:38061117
Utility of CD229 as novel marker in measurable residual disease assessment in multiple myeloma-An evidence-based approach., PMID:36403963
Immunophenotypic Characterization and Ploidy Analysis of Neoplastic Plasma Cells by Multiparametric Flow Cytometry., PMID:35747566
CD229 (Ly9) a Novel Biomarker for B-Cell Malignancies and Multiple Myeloma., PMID:35565280
Low-affinity CAR T cells exhibit reduced trogocytosis, preventing rapid antigen loss, and increasing CAR T cell expansion., PMID:35490197
Roadmap to affinity-tuned antibodies for enhanced chimeric antigen receptor T cell function and selectivity., PMID:35078657
CD319 (SLAMF7) an alternative marker for detecting plasma cells in the presence of daratumumab or elotuzumab., PMID:33017079
Proteomic markers with prognostic impact on outcome of chronic lymphocytic leukemia patients under chemo-immunotherapy: results from the HOVON 109 study., PMID:32781097
CD229 CAR T cells eliminate multiple myeloma and tumor propagating cells without fratricide., PMID:32034142
Upregulation of SLAMF3 on human T cells is induced by palmitic acid through the STAT5-PI3K/Akt pathway and features the chronic inflammatory profiles of type 2 diabetes., PMID:31332162
Ly9 (CD229) Antibody Targeting Depletes Marginal Zone and Germinal Center B Cells in Lymphoid Tissues and Reduces Salivary Gland Inflammation in a Mouse Model of Sjögren's Syndrome., PMID:30519241
The role of surface molecule CD229 in Multiple Myeloma., PMID:30326256
Evaluation of CD229 as a new alternative plasma cell gating marker in the flow cytometric immunophenotyping of monoclonal gammopathies., PMID:29316178
Cell surface markers for the identification and study of human naive pluripotent stem cells., PMID:29227830
Ly9 (SLAMF3) receptor differentially regulates iNKT cell development and activation in mice., PMID:28980301
Novel anti-myeloma immunotherapies targeting the SLAM family of receptors., PMID:28638731
Targeting of Ly9 (CD229) Disrupts Marginal Zone and B1 B Cell Homeostasis and Antibody Responses., PMID:26667173
Multiple myeloma: New surface antigens for the characterization of plasma cells in the era of novel agents., PMID:26287276
Utility of CD54, CD229, and CD319 for the identification of plasma cells in patients with clonal plasma cell diseases., PMID:26130131
CD229 is expressed on the surface of plasma cells carrying an aberrant phenotype and chemotherapy-resistant precursor cells in multiple myeloma., PMID:26001047
The expression of the hepatocyte SLAMF3 (CD229) receptor enhances the hepatitis C virus infection., PMID:24927415
Systemic lupus erythematosus immune complexes increase the expression of SLAM family members CD319 (CRACC) and CD229 (LY-9) on plasmacytoid dendritic cells and CD319 on CD56(dim) NK cells., PMID:23956418
Ly9 (CD229) Cell-Surface Receptor is Crucial for the Development of Spontaneous Autoantibody Production to Nuclear Antigens., PMID:23914190
CD3-T cell receptor co-stimulation through SLAMF3 and SLAMF6 receptors enhances RORγt recruitment to the IL17A promoter in human T lymphocytes., PMID:22989874
Human cytomegalovirus UL7, a homologue of the SLAM-family receptor CD229, impairs cytokine production., PMID:21670740
Surface molecule CD229 as a novel target for the diagnosis and treatment of multiple myeloma., PMID:21606160
Mutual benefits of B-ALL and HLDA/HCDM HLDA 9th Barcelona 2010., PMID:20951742
Expression of SLAM (CD150) cell-surface receptors on human B-cell subsets: from pro-B to plasma cells., PMID:20933013
Analysis of HLDA9 mAbs on plasmacytoid dendritic cells., PMID:20933012
Differential expression of SLAMS and other modulatory molecules by human plasma cells during normal maturation., PMID:20923684
Characterization of mouse CD229 (Ly9), a leukocyte cell surface molecule of the CD150 (SLAM) family., PMID:17919264
Ly9 (CD229)-deficient mice exhibit T cell defects yet do not share several phenotypic characteristics associated with SLAM- and SAP-deficient mice., PMID:16365421
Fine-tuning of immune responses by SLAM-related receptors., PMID:16365151
CD229 (Ly9) lymphocyte cell surface receptor interacts homophilically through its N-terminal domain and relocalizes to the immunological synapse., PMID:15905546
Identification of Grb2 as a novel binding partner of the signaling lymphocytic activation molecule-associated protein binding receptor CD229., PMID:15879090
Molecular and cellular pathogenesis of X-linked lymphoproliferative disease., PMID:15661030
Differential expression of SAP and EAT-2-binding leukocyte cell-surface molecules CD84, CD150 (SLAM), CD229 (Ly9) and CD244 (2B4)., PMID:15245368
Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells., PMID:15162436
Functional requirements for interactions between CD84 and Src homology 2 domain-containing proteins and their contribution to human T cell activation., PMID:12928397
The cell surface expression of SAP-binding receptor CD229 is regulated via its interaction with clathrin-associated adaptor complex 2 (AP-2)., PMID:12621057
Mouse novel Ly9: a new member of the expanding CD150 (SLAM) family of leukocyte cell-surface receptors., PMID:12242590
Identification and characterization of SF2000 and SF2001, two new members of the immune receptor SLAM/CD2 family., PMID:11862385
Structural basis for the interaction of the free SH2 domain EAT-2 with SLAM receptors in hematopoietic cells., PMID:11689425
CD84 functions as a homophilic adhesion molecule and enhances IFN-gamma secretion: adhesion is mediated by Ig-like domain 1., PMID:11564780
Activation of lymphocytes inhibits human monocyte to macrophage differentiation., PMID:11563672
CD150 is a member of a family of genes that encode glycoproteins on the surface of hematopoietic cells., PMID:11486275
XLP: one gene, many players., PMID:11414739
Molecular characterization and expression of a novel human leukocyte cell-surface marker homologous to mouse Ly-9., PMID:11369645
Genetic approach to insight into the immunobiology of human dendritic cells and identification of CD84-H1, a novel CD84 homologue., PMID:11300479
For research use only. Not for human or drug use.
